Tovey MG - Search Results

1

Overcoming immunogenicity associated with the use of biopharmaceuticals.

Tovey MG, Legrand J, Lallemand C. Tovey MG, et al. Expert Rev Clin Pharmacol. 2011 Sep;4(5):623-31. doi: 10.1586/ecp.11.39. Expert Rev Clin Pharmacol. 2011. PMID: 22114889 Review.

2

Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticals.

Tovey MG, Lallemand C. Tovey MG, et al. Bioanalysis. 2012 Sep;4(17):2179-90. doi: 10.4155/bio.12.186. Bioanalysis. 2012. PMID: 23013400 Review.

3

Immunogenicity and other problems associated with the use of biopharmaceuticals.

Tovey MG, Lallemand C. Tovey MG, et al. Ther Adv Drug Saf. 2011 Jun;2(3):113-28. doi: 10.1177/2042098611406318. Ther Adv Drug Saf. 2011. PMID: 25083207 Free PMC article. Review.

4

Safety, Tolerability, and Immunogenicity of Interferons.

Tovey MG, Lallemand C. Tovey MG, et al. Pharmaceuticals (Basel). 2010 Apr 20;3(4):1162-1186. doi: 10.3390/ph3041162. Pharmaceuticals (Basel). 2010. PMID: 27713294 Free PMC article. Review.

5

One-step assay for quantification of neutralizing antibodies to biopharmaceuticals.

Lallemand C, Meritet JF, Blanchard B, Lebon P, Tovey MG. Lallemand C, et al. Among authors: tovey mg. J Immunol Methods. 2010 Apr 30;356(1-2):18-28. doi: 10.1016/j.jim.2010.03.003. Epub 2010 Mar 15. J Immunol Methods. 2010. PMID: 20298696

6

Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists.

Lallemand C, Kavrochorianou N, Steenholdt C, Bendtzen K, Ainsworth MA, Meritet JF, Blanchard B, Lebon P, Taylor P, Charles P, Alzabin S, Tovey MG. Lallemand C, et al. Among authors: tovey mg. J Immunol Methods. 2011 Oct 28;373(1-2):229-39. doi: 10.1016/j.jim.2011.08.022. Epub 2011 Sep 3. J Immunol Methods. 2011. PMID: 21910993

7

Adjuvant activity of interferon alpha: mechanism(s) of action.

Tovey MG, Lallemand C, Meritet JF, Maury C. Tovey MG, et al. Vaccine. 2006 Apr 12;24 Suppl 2:S2-46-7. doi: 10.1016/j.vaccine.2005.01.117. Vaccine. 2006. PMID: 16823922

8

Adjuvant activity of cytokines.

Tovey MG, Lallemand C. Tovey MG, et al. Methods Mol Biol. 2010;626:287-309. doi: 10.1007/978-1-60761-585-9_19. Methods Mol Biol. 2010. PMID: 20099135 Review.

9

Adjuvant activity of type I interferons.

Tovey MG, Lallemand C, Thyphronitis G. Tovey MG, et al. Biol Chem. 2008 May;389(5):541-5. doi: 10.1515/bc.2008.051. Biol Chem. 2008. PMID: 18953720 Review.

10

Effect of sublingual administration of interferon-alpha on the immune response to influenza vaccination in institutionalized elderly individuals.

Launay O, Grabar S, Bloch F, Desaint C, Jegou D, Lallemand C, Erickson R, Lebon P, Tovey MG. Launay O, et al. Among authors: tovey mg. Vaccine. 2008 Jul 29;26(32):4073-9. doi: 10.1016/j.vaccine.2008.05.035. Epub 2008 Jun 4. Vaccine. 2008. PMID: 18602725 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters